271 Invasive Network Mapping Enables Personalized Multi-Nodal Deep Brain Stimulation for Treatment-Refractory Chronic Pain

View at publisher Summarise with VIRAT
Authors: Yuhao Huang, Paul D. McGeoch, Neda Kaboodvand, Tony X. Liu, Brandon T. Reid, Adelaida Chibukhchyan, Kishandra Patron, Lisa Yamada, Adam S. Fogarty, Eun Young Choi, Camarin E. Rolle, Mensure Polat
+4 more Ashwin G. Ramayya, Paul Nuyujukian, Karl A. Deisseroth, Vivek Buch
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Deep brain stimulation (DBS) for chronic pain has shown inconsistent outcomes, largely due to empirical target selection and patient heterogeneity. This is particularly evident in anesthesia dolorosa (AD), a debilitating facial pain condition refractory to standard treatments. METHODS: A 44-year-old woman with intractable facial pain (left-sided AD and right trigeminal deafferentation) underwent sEEG implantation targeting pain-processing regions, including novel thermosensory nodes (VMpo, dpIns). Over five inpatient days, stimulation mapping identified sites of acute pain reduction, with intensity and unpleasantness rated in real-time. Concurrently, intracranial EEG (iEEG) data were analyzed for biomarkers correlating with pain states and relief. Subsequently, four permanent DBS leads were implanted, guided by these findings. Outcomes over 12 months were assessed using thermal quantitative sensory testing (QST) and daily remotely-captured pain scores. RESULTS: Personalized invasive mapping identified 26 distinct anatomical locations where stimulation reliably reduced facial pain, including established (M1, VPM, PVG, ACC) and novel (VMpo, dpIns, AI) targets. Acute stimulation significantly reduced contralateral facial pain (mean 34-54%). Anterior cingulate cortex (ACC) high-gamma suppression strongly correlated with pain relief and decoded pain states (AUC=0.84). Mapping-guided four-lead DBS implantation led to sustained at-home pain reduction at 6 and 12 months, with normalized thermal QST thresholds. Deactivating an ipsilateral VMpo/PVG electrode unexpectedly increased pain, suggesting a role for hemispheric balance. CONCLUSIONS: Personalized sEEG network mapping is a feasible, effective strategy for identifying patient-specific DBS targets in treatment-refractory chronic pain. This biomarker-guided, multi-nodal approach yielded significant, sustained pain relief and objective sensory improvements, offering a promising data-driven personalization for DBS.

Fields of Study & Subjects

Deep Brain Stimulation and Movement Disorders Pain Management and Treatment Trigeminal Neuralgia and Treatments

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
66–66
Publication date
26 March 2026
Language
EN